Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Atyr Pharma Inc (ATYR)

Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 80,731
  • Shares Outstanding, K 97,987
  • Annual Sales, $ 240 K
  • Annual Income, $ -64,020 K
  • EBIT $ -79 M
  • EBITDA $ -80 M
  • 60-Month Beta 0.57
  • Price/Sales 345.16
  • Price/Cash Flow N/A
  • Price/Book 1.01
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.83
  • Most Recent Earnings $-0.26 on 11/06/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 268.77% (-265.78%)
  • Historical Volatility 85.95%
  • IV Percentile 71%
  • IV Rank 17.75%
  • IV High 1,155.84% on 10/08/25
  • IV Low 77.30% on 06/16/25
  • Expected Move (DTE 6) 0.0085 (1.03%)
  • Put/Call Vol Ratio 0.49
  • Today's Volume 333
  • Volume Avg (30-Day) 751
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 73,140
  • Open Int (30-Day) 87,643
  • Expected Range 0.8154 to 0.8324

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.18
  • Number of Estimates 3
  • High Estimate -0.15
  • Low Estimate -0.20
  • Prior Year -0.18
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6400 +28.73%
on 11/21/25
0.8596 -4.15%
on 12/04/25
+0.0101 (+1.24%)
since 11/05/25
3-Month
0.6400 +28.73%
on 11/21/25
6.5000 -87.32%
on 09/12/25
-4.7861 (-85.31%)
since 09/05/25
52-Week
0.6400 +28.73%
on 11/21/25
7.2904 -88.70%
on 07/28/25
-2.4461 (-74.80%)
since 12/05/24

Most Recent Stories

More News
Investors who lost money on aTyr Pharma, Inc.(ATYR) should contact Levi & Korsinsky about pending Class Action - ATYR

NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in  aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ: ATYR) of a class action securities lawsuit.

ATYR : 0.8239 (-0.47%)
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , Dec. 5, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action...

ATYR : 0.8239 (-0.47%)
ATYR 3-DAY DEADLINE ALERT: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure

Securities Class Action Pending Over Key Drug's Efficacy

ATYR : 0.8239 (-0.47%)
Deadline Soon: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz reminds investors of the upcoming December 8, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed...

ATYR : 0.8239 (-0.47%)
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their Options

ATYR : 0.8239 (-0.47%)
aTyr Pharma, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before December 8, 2025 to Discuss Your Rights - ATYR

NEW YORK , Dec. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of  aTyr Pharma, Inc. (NASDAQ: ATYR).

ATYR : 0.8239 (-0.47%)
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , Dec. 4, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against aTyr Pharma, Inc....

ATYR : 0.8239 (-0.47%)
aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

LOS ANGELES , Dec. 4, 2025 /PRNewswire/ -- The DJS Law Group  announces that it is investigating claims on behalf of investors of aTyr Pharma, Inc. ("aTyr" or "the Company") (NASDAQ: ATYR...

ATYR : 0.8239 (-0.47%)
ATYR 5-DAY DEADLINE ALERT: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure

Securities Class Action Pending Over Key Drug's Efficacy

ATYR : 0.8239 (-0.47%)
ATYR Deadline: ATYR Investors with Losses Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit

NEW YORK , Dec. 2, 2025 /PRNewswire/ --

ATYR : 0.8239 (-0.47%)

Business Summary

aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States.

See More

Key Turning Points

3rd Resistance Point 0.8858
2nd Resistance Point 0.8678
1st Resistance Point 0.8459
Last Price 0.8239
1st Support Level 0.8060
2nd Support Level 0.7880
3rd Support Level 0.7661

See More

52-Week High 7.2904
Fibonacci 61.8% 4.7499
Fibonacci 50% 3.9652
Fibonacci 38.2% 3.1805
Last Price 0.8239
52-Week Low 0.6400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar